Skip to main content
Fig. 5 | BMC Complementary Medicine and Therapies

Fig. 5

From: Anti-obesity effect of Neoagaro-oligosaccharides with overweight and obese subjects: a 16-week, randomized, double-blind, placebo-controlled clinical trial

Fig. 5

Change in anthropometric parameters. (A) Weight, (B) Body mass index (BMI) were measured in NAOs and placebo treated groups at baseline and 16 weeks. Values are presented as mean ± SD. Between-group differences were assessed using independent t-test for change value between the groups. **p < 0.01 vs. placebo group. NAOs, Neoagaro-oligosaccharides; BMI, body mass index

Back to article page